Satellite Banner
Technology Networks Header
Wednesday, November 26, 2014
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Proteomics for Systems Toxicology
MS-based proteomics is maturing into a robust technology for the measurement of proteome-wide exposure effects.
Schizophrenia May be Triggered by Excess Protein, Rutgers Study Finds
Neuroscientist Bonnie Firestein says too much causes abnormalities in brain development.
Protein-engineered Cages Aid Studies of Cell Functions
The Cages, from researchers at Tokyo Institute of Technology, to deliver an important signalling molecule, carbon monoxide, into cells.
UCLA Biochemists Build Largest Synthetic Molecular ‘Cage’ Ever
New nanoscale protein container could lead to synthetic vaccines and offer a way to deliver medicine inside of human cells.
Almac Announces Launch of CLIA Validated Next Generation Sequencing Assay
P53 considered important biomarker for cancer drug discovery.
Blood Test Could Reduce Antibiotic Use
A new blood biomarker test that indicates whether bacteria is the cause of a patient’s lung infection is now being studied at UPMC Presbyterian.
New Targets and Test to Develop Treatments for Memory Disorders
The study focuses on kinesin, a molecular motor protein that plays a role in the transport of other proteins throughout a cell.
Classification of Gene Mutations in Neuroblastoma
Penn Medicine and CHOP experts define riskier mutations in neuroblastoma, setting stage for clinical trial.
Could Non-gluten Proteins Play a Role in Celiac Disease?
Scientists are reporting in ACS’ Journal of Proteome Research that people with the disease also have reactions to non-gluten wheat proteins.
Researcher Debunks Alzheimer's Prevailing Development Theory
New research helps explains why some people with plaque buildup in their brains don’t develop dementia.
Scroll Up
Scroll Down

Webinar: How to Overcome Assay Challenges Using Custom Recombinant Antibodies
Join this webinar to find out how custom-made recombinant antibodies can solve your challenges when designing and optimizing critical assays to support drug development, diagnostic assays or discovery studies.

qPCR as a Tool for Early Detection of Alzheimer´s Disease
Petar Podlesniy, Institut d'Investigacions Biomediques August Pi i Sunyer, speaking at Advances in qPCR and dPCR 2014

Combining Computational Biology and High Content Imaging Approaches for Understanding DNA Damage and Repair
Thierry Dorval, AstraZeneca, speaking at High Content Analysis 2014

Advanced Molecular Tools for Proteome Analyses
Masood Kamali-Moghaddam, Uppsala University, speaking at Advances ibn qPCR and dPCR 2014

Conformational Changes Induced by Nanomaterials: Functional Implications
Rosana Simon-Vazquez, University of Vigo, speaking at Nanomedicine 2014.

Magneto-plasmonic Nanoparticle Platform for Capture, Separation and Enumeration of Rare Cells
Konstantin Sokolov, The University of Texas at Austin, speaking at Nanomedicine 2014.

Microfluidic Systems for Biomarker Analysis and Cancer Diagnosis
Martin Gijs, Ecole Polytechnique Federale de Lausanne, speaking at Lab-on-a-Chip European Congress 2014.

TagLite® 2 cell assay - the next dimension to discovering new antibody drugs
Sandra Grau-Richards, Senior Scientist/Team Leader Roche-Glycart

Multiplexed Assays for Diagnostics and Environment
Loic Blum, Universite Lyon, speaking at Advances in Biodetection & Biosensors 2014.

Advances in Volatile Analyses for Disease Diagnosis
Norman Ratcliffe, University of the West of England, speaking at Advances in Biodetection & Biosensors 2014.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 144
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv